Shining a Light on Rare Diseases: Raising Awareness Together
At Plus Therapeutics, we are committed to advancing research and innovative treatments for rare and challenging diseases. Today, on Rare Disease Day, we stand with patients, caregivers, and advocates worldwide to raise awareness and drive progress toward better care and treatment options.
Did you know? Over 300 million people worldwide are living with a rare disease, yet many conditions remain underdiagnosed and misunderstood. Increased awareness, research, and collaboration are essential in bringing hope to those affected.
As a clinical-stage pharmaceutical company, we are dedicated to developing targeted radiotherapeutics for rare and aggressive cancers, including recurrent glioblastoma (rGBM) and leptomeningeal metastases (LM). Through our ReSPECT-GBM and ReSPECT-LM clinical trials, we strive to provide new treatment options where few exist.
This Rare Disease Day, join us in spreading awareness and supporting the rare disease community. Together, we can make a difference.
🔬 Learn more about our research: PlusTherapeutics.com
#RareDiseaseDay #RareDiseases #ClinicalResearch #PatientAdvocacy #HopeForRare
Recent Comments